CRISPR/Cas9 technology generated a T to G point mutation at position 273 (T273G) that changes serine 92 to alanine. In addition, two silent point mutations (C263T and A269G) were generated to disrupt cutting by Cas9 after HDR. The S92A mutation prevents luteinizing hormone-induced phosphorylation at this site. (J:258770)